Bellafill Receives FDA Approval for Treatment of Acne Scars

San Diego, CA (Jan. 6, 2015)—Suneva Medical, Inc., a privately-held aesthetics company, announced today that the U.S. Food and Drug Administration (FDA) has approved the dermal filler, Bellafill®, for the treatment of acne scars. Bellafill represents a significant clinical advancement as the only injectable filler approved for the correction of moderate to severe atrophic acne scars on the cheek. To discover more about how this treatment can fit into a comprehensive facial aesthetic plan, read our overview on what Bellafill is good for and how it supports long-term skin structure.